TrialPloS one2015

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.

Gloria Omosa-Manyonyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.